Trials of new treatments go in phases. Phase 1 checks safety in a small group, phase 2 looks for effects in a larger group, and phase 3 tests the treatment in hundreds or thousands of people. Regulators like the FDA usually need phase 3 results before approving a drug.
Phase 3 trial
A large trial in people, usually the last step before a drug can be approved.